Clinical Trial Update: Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy and safety of STG320 sublingual tablets containing house dust mite allergen extracts in adults and adolescents with perenni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• House Dust Mite Allergy

Drugs mentioned

• STG320 sublingual tablets (HDM allergen extract)

Snippet

Sponsor: Stallergenes Greer | Conditions: Rhinitis, Allergic, Perennial, House Dust Mite Allergy | Phase 3 | Status: COMPLETED | Results posted: 2019-09-25